Charles W. Newton

Insider Reports History

Entity
Individual
Location
46 Fredrick Avenue, Atherton, CA
Signature
/s/ Iya Kessler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles W. Newton:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Lyell Immunopharma, Inc. Chief Financial Officer Common Stock 48.7K $111K $2.28 Feb 9, 2024 Direct
2seventy bio, Inc. Director Common Stock 22.6K $94.6K $4.18 Jun 10, 2024 Direct
2seventy bio, Inc. Director Stock Options (Right to buy) 12.1K $47.4K $3.93 Jun 10, 2024 Direct
Lyell Immunopharma, Inc. Chief Financial Officer Stock Option (right to buy) 400K Feb 9, 2024 Direct
Coherus BioSciences, Inc. Director Stock Option (Right to Buy) 112K Jun 3, 2024 Direct

Insider Reports Filed by Charles W. Newton

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSVT 2seventy bio, Inc. Jun 10, 2024 2 $0 4 Jun 12, 2024 Director
CHRS Coherus BioSciences, Inc. Jun 3, 2024 1 $0 4 Jun 5, 2024 Director
TSVT 2seventy bio, Inc. Mar 20, 2024 2 $0 4 Mar 25, 2024 Director
TSVT 2seventy bio, Inc. Mar 20, 2024 0 $0 3 Mar 25, 2024 Director
LYEL Lyell Immunopharma, Inc. Feb 9, 2024 2 $0 4 Feb 13, 2024 Chief Financial Officer
LYEL Lyell Immunopharma, Inc. Nov 16, 2023 8 $0 4 Nov 20, 2023 Chief Financial Officer
CHRS Coherus BioSciences, Inc. Jun 7, 2023 1 $0 4 Jun 9, 2023 Director
LYEL Lyell Immunopharma, Inc. Feb 24, 2023 1 $0 4 Feb 28, 2023 Chief Financial Officer
CHRS Coherus BioSciences, Inc. May 4, 2022 1 $0 4 May 6, 2022 Director
CHRS Coherus BioSciences, Inc. May 4, 2022 0 $0 3 May 6, 2022 Director
CHRS Coherus BioSciences, Inc. May 4, 2022 0 $0 3 May 6, 2022 Director
LYEL Lyell Immunopharma, Inc. Mar 16, 2022 1 $0 4 Mar 18, 2022 Chief Financial Officer
LYEL Lyell Immunopharma, Inc. Jun 16, 2021 0 $0 3 Jun 16, 2021 Chief Financial Officer